Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin

Malaria, an ancient mosquito-borne illness caused by Plasmodium parasites, is mostly treated with Artemisinin Combination Therapy (ACT). However, Single Nucleotide Polymorphisms (SNPs) mutations in the P. falciparum Kelch 13 (PfK13) protein have been associated with artemisinin resistance (ART-R). T...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Author: Yusuf N.M.; Azman A.N.; Aziz A.A.A.; Fuad F.A.A.; Nasarudin R.N.; Hisam S.
Format: Article
Language:English
Published: Public Library of Science 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85201370409&doi=10.1371%2fjournal.pone.0306975&partnerID=40&md5=d000c3a6f64e794164588796a321476e
id 2-s2.0-85201370409
spelling 2-s2.0-85201370409
Yusuf N.M.; Azman A.N.; Aziz A.A.A.; Fuad F.A.A.; Nasarudin R.N.; Hisam S.
Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
2024
PLoS ONE
19
8-Aug
10.1371/journal.pone.0306975
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85201370409&doi=10.1371%2fjournal.pone.0306975&partnerID=40&md5=d000c3a6f64e794164588796a321476e
Malaria, an ancient mosquito-borne illness caused by Plasmodium parasites, is mostly treated with Artemisinin Combination Therapy (ACT). However, Single Nucleotide Polymorphisms (SNPs) mutations in the P. falciparum Kelch 13 (PfK13) protein have been associated with artemisinin resistance (ART-R). Therefore, this study aims to generate PfK13 recombinant proteins incorporating of two specific SNPs mutations, PfK13-V494I and PfK13-N537I, and subsequently analyze their binding interactions with artemisinin (ART). The recombinant proteins of PfK13 mutations and the Wild Type (WT) variant were expressed utilizing a standard protein expression protocol with modifications and subsequently purified via IMAC and confirmed with SDS-PAGE analysis and Orbitrap tandem mass spectrometry. The binding interactions between PfK13-V494I and PfK13-N537I propeller domain proteins ART were assessed through Isothermal Titration Calorimetry (ITC) and subsequently validated using fluorescence spectrometry. The protein concentrations obtained were 0.3 mg/ml for PfK13-WT, 0.18 mg/ml for PfK13-V494I, and 0.28 mg/ml for PfK13-N537I. Results obtained for binding interaction revealed an increased fluorescence intensity in the mutants PfK13-N537I (83 a.u.) and PfK13-V494I (143 a.u.) compared to PfK13-WT (33 a.u.), indicating increased exposure of surface proteins because of the looser binding between PfK13 protein mutants with ART. This shows that the PfK13 mutations may induce alterations in the binding interaction with ART, potentially leading to reduced effectiveness of ART and ultimately contributing to ART-R. However, this study only elucidated one facet of the contributing factors that could serve as potential indicators for ART-R and further investigation should be pursued in the future to comprehensively explore this complex mechanism of ART-R. © 2024 Md. Yusuf et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Public Library of Science
19326203
English
Article

author Yusuf N.M.; Azman A.N.; Aziz A.A.A.; Fuad F.A.A.; Nasarudin R.N.; Hisam S.
spellingShingle Yusuf N.M.; Azman A.N.; Aziz A.A.A.; Fuad F.A.A.; Nasarudin R.N.; Hisam S.
Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
author_facet Yusuf N.M.; Azman A.N.; Aziz A.A.A.; Fuad F.A.A.; Nasarudin R.N.; Hisam S.
author_sort Yusuf N.M.; Azman A.N.; Aziz A.A.A.; Fuad F.A.A.; Nasarudin R.N.; Hisam S.
title Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
title_short Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
title_full Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
title_fullStr Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
title_full_unstemmed Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
title_sort Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin
publishDate 2024
container_title PLoS ONE
container_volume 19
container_issue 8-Aug
doi_str_mv 10.1371/journal.pone.0306975
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85201370409&doi=10.1371%2fjournal.pone.0306975&partnerID=40&md5=d000c3a6f64e794164588796a321476e
description Malaria, an ancient mosquito-borne illness caused by Plasmodium parasites, is mostly treated with Artemisinin Combination Therapy (ACT). However, Single Nucleotide Polymorphisms (SNPs) mutations in the P. falciparum Kelch 13 (PfK13) protein have been associated with artemisinin resistance (ART-R). Therefore, this study aims to generate PfK13 recombinant proteins incorporating of two specific SNPs mutations, PfK13-V494I and PfK13-N537I, and subsequently analyze their binding interactions with artemisinin (ART). The recombinant proteins of PfK13 mutations and the Wild Type (WT) variant were expressed utilizing a standard protein expression protocol with modifications and subsequently purified via IMAC and confirmed with SDS-PAGE analysis and Orbitrap tandem mass spectrometry. The binding interactions between PfK13-V494I and PfK13-N537I propeller domain proteins ART were assessed through Isothermal Titration Calorimetry (ITC) and subsequently validated using fluorescence spectrometry. The protein concentrations obtained were 0.3 mg/ml for PfK13-WT, 0.18 mg/ml for PfK13-V494I, and 0.28 mg/ml for PfK13-N537I. Results obtained for binding interaction revealed an increased fluorescence intensity in the mutants PfK13-N537I (83 a.u.) and PfK13-V494I (143 a.u.) compared to PfK13-WT (33 a.u.), indicating increased exposure of surface proteins because of the looser binding between PfK13 protein mutants with ART. This shows that the PfK13 mutations may induce alterations in the binding interaction with ART, potentially leading to reduced effectiveness of ART and ultimately contributing to ART-R. However, this study only elucidated one facet of the contributing factors that could serve as potential indicators for ART-R and further investigation should be pursued in the future to comprehensively explore this complex mechanism of ART-R. © 2024 Md. Yusuf et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
publisher Public Library of Science
issn 19326203
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1812871794498994176